Clough Capital Partners’s BeOne Medicines Ltd ONC Stock Holding History

Clough Capital Partners’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,860	Closed	-$1.86M	–	153
2020 Q2	$1.86M	Sell	9,860 -2,470	-20%	-$402K	0.18%	90
2020 Q1	$1.52M	Sell	12,330 -60,790	-83%	-$9.51M	0.15%	73
2019 Q4	$12.1M	Sell	73,120 -29,510	-29%	-$4.9M	1.03%	38
2019 Q3	$12.6M	Buy	102,630 +11,870	+13%	+$1.58M	1.04%	28
2019 Q2	$11.3M	Buy	90,760 +43,050	+90%	+$5.46M	1.1%	31
2019 Q1	$6.3M	Sell	47,710 -23,800	-33%	-$3.21M	0.55%	64
2018 Q4	$10M	Buy	+71,510	New	+$9.48M	1.18%	23

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Clough Capital Partners's ONC Position: Q3 2020 in Review

Clough Capital Partners sold out of BeOne Medicines Ltd (ONC) in Q3 2020, closing a stake of 9,860 shares — an estimated $1.86M sold.

Clough Capital Partners first reported a position in ONC in Q4 2018 and held it in 7 quarters. The position peaked at $12.6M in Q3 2019. 244 funds tracked by Wall St. Rank hold ONC as of Q3 2020.

Clough Capital Partners reported no remaining BeOne Medicines Ltd position as of Q3 2020 after selling out during the quarter.
Clough Capital Partners sold 9,860 BeOne Medicines Ltd shares in Q3 2020, an estimated $1.86M.
Clough Capital Partners first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 7 quarters.
Clough Capital Partners's BeOne Medicines Ltd position peaked at $12.6M in Q3 2019.
244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2020.

Based on Clough Capital Partners's 13F filing for Q3 2020, filed 17 Nov 2020.